HOME >> BIOLOGY >> NEWS
USC researchers determine mechanism of action of chemotherapy drug

LOS ANGELES, May 1 - The chemotherapy drug motexafin gadolinium (brand name: Xcytrin, manufactured by Pharmacyclics, Inc.) works to thwart cancer cells by disrupting key enzymes involved in cellular metabolism, according to a team of researchers led by Joseph Hacia, Ph.D., assistant professor of biochemistry and molecular biology at the Keck School of Medicine of the University of Southern California.

The cellular disruption results in increases in the amount of zinc available inside the cancer cells, and because zinc is involved in protein structure and function, leads to inhibition of enzyme activity and to the death of the cells.

A paper describing these findings was published in the May 1, 2005, issue of the journal Cancer Research.

In order to gain a better understanding of the mechanism of action of this novel chemotherapeutic agent, the researchers looked at gene expression profiles and other biochemical properties of cells from human lung, prostate and lymphoma cancer cell cultures that had been treated with motexafin gadolinium, or MGd. What they found was that the drug created oxidative stress in the tumor cells, increasing the levels of expression of the genes that produce metallothioneins.

The researchers showed that the increased metallothionein expression levels resulted from significantly increased levels of free-i.e., not protein-bound-zinc in the cells. The zinc, in turn, acted to inhibit an enzyme-thioredoxin reductase-that is an important component in the cell's antioxidant system, as well as important in DNA synthesis. In other words, thioredoxin reductase is key to the replication and survival of cells, and its inhibition ultimately leads to cell death.

"Our studies showed that MGd induces oxidative stress in cancer cells," says Hacia, who is a member of USC's Institute for Genetic Medicine, "and this leads to disruption of zinc metabolism and alteration of key enzymes and metabolites necessary for normal
'"/>

Contact: Sarah Huoh
shuoh@usc.edu
323-442-2830
University of Southern California
1-May-2005


Page: 1 2

Related biology news :

1. Innovative tagging technique may help researchers better protect fish stocks
2. Penn researchers discover how key protein stops inflammation
3. ASU researchers partner with UOP to make biofuel for military jets a reality
4. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
5. Penn researchers discover pathway that eliminates genetic defects in red blood cells
6. U-M researchers find family of on switches that cause prostate cancer
7. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
8. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
9. MGH researchers confirm that bone marrow restores fertility in female mice
10. Smithsonians National Zoo researchers use electronic eggs to help save threatened species
11. U-M researchers identify gene involved in breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/2/2019)... ... January 31, 2019 , ... ... NC, providing full, customizable clinical research services across multiple therapeutic areas, announced ... for early stage life science entrepreneurs in the Research Triangle region of ...
(Date:1/25/2019)... ... January 24, 2019 , ... GrowthZone, Inc., ... Survey. The report indicates membership growth in some sectors and decreasing membership among ... received responses from over 500 association professionals across North America. , “This ...
(Date:1/20/2019)... , ... January 16, 2019 , ... As the leader ... through the introduction of its own liver 3D cell culture models. In an effort ... models, protocols and validation criteria so that any researcher can replicate these models for ...
Breaking Biology News(10 mins):
(Date:2/6/2019)... ... February 05, 2019 , ... Firmex announced today that ... to acquire Firmex, one of the fastest-growing and most widely-used providers of virtual ... firm. Debt financing was provided by the Bank of Montreal. , Headquartered in ...
(Date:2/2/2019)... ... January 31, 2019 , ... Dust off your Doc Martens, Virun ... the Nuriv 2019 Expo West Music and Tech Festival at the ESports Arena in ... in the natural foods, beverages, and dietary supplement industries, the Nuriv Music and Tech ...
(Date:2/2/2019)... ... February 01, 2019 , ... Biomatlante, a world ... its new CEO, Julien Dert, being effective on February 1st, 2019. , Graduated ... and management, in which more than 12 years in the Medical Device industry. ...
(Date:1/30/2019)... ... January 29, 2019 , ... ... Manufacturing Organization (CDMO) serving the global biopharmaceutical and biotechnology industries with sites in ... million backed by multiple global investors lead by China's State Development & Investment ...
Breaking Biology Technology:
Cached News: